Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 24 February 2026 - 16:12

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 24 February 2026 - 16:00

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 51, Status: Authorised

Submitted by Anonymous (not verified) on 24 February 2026 - 15:38

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 24 February 2026 - 15:32

Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 21, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness